1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide- induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes

Clinical and Experimental Immunology

Volumn 112, Issue 2, 1998, Pages 181-187

  Casteels, K ^a   Waer, M ^a   Bouillon, R ^a   Depovere, J ^a   Valckx, D ^a   Laureys, J ^a   Mathieu, C ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b LEGENDO   (Belgium)

Author keywords

Apoptosis; NOD; Prevention; Vitamin D

Indexed keywords

CALCITRIOL; CYCLOPHOSPHAMIDE; VITAMIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL FUNCTION; CELL POPULATION; EFFECTOR CELL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUPPRESSOR CELL; THYMOCYTE; WEANING;

ANIMALS; APOPTOSIS; CALCITRIOL; CYCLOPHOSPHAMIDE; CYTOKINES; DIABETES MELLITUS, TYPE 1; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MICE; MICE, INBRED NOD; RNA, MESSENGER;

EID: 0031752298     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00568.x     Document Type: Article

References (36)

1. 3 prevents insulitis in NOD mice. Diabetes 1992; 41:1491-5.
2. 3. Diabetologia 1994; 37:552-8.
3. Harada M, Makino S. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 1984; 27:604-6.
4. Yasunami R, Bach JF. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 1988; 18:481-4.
5. Mitsuoka A, Baba M, Morikawa S. Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice. Nature 1976; 262:77-78.
6. Charlton B, Bacelj A, Slattery R, Mandel T. Cyclophosphamide-induced diabetes in NOD/WEHI mice: evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes 1989; 38:441-7.
7. Rothe H, Faust A, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H. Cyclophosphamide treatment of female NOD mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 1994; 37:1154-8.
8. Rothe H, Burkart V, Faust A, Kolb H. Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia 1996; 39:119-22.
9. Qin HY, Sadelain M, Hitchon C, Lauzon J, Singh B. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol 1993; 150:2072-80.
10. Lakey J, Singh B, Warnock G, Elliott J, Rajotte R. Long-term survival of syngeneic islet grafts in BCG-treated diabetic NOD mice can be reversed by cyclophosphamide. Transplantation 1995; 59:1751-3.
11. Shintani S, Satoh J, Seino H, Goto Y, Toyota T. Mechanism of action of a streptococcal preparation (OK-432) in prevention of autoimmune diabetes in NOD mice. J Immunol 1990; 144:136-41.
12. Mountz J, Wu J, Cheng J, Zhou T. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 1994; 37:1415-20.
13. Watanabe-Fukunaga R, Brannan C, Copeland N, Jenkins N, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-7.
14. Takahashi T, Tamaka M, Brannan C, Jenkins N, Copeland N, Suda T, Nagata S. Generalised lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell 1994; 76:969-76.
15. McDonnel T, Deane N, Platt F, Nunez G, Jaeger U, McKearn J, Korsmeyer S. Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989; 57:79-88.
16. Strasser A, Whittingham S, Vaux D, Bath M, Adams J, Cory S, Harris H. Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 1991; 88:8861-5.
17. Strasser A, Harris A, Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991; 67:889-99.
18. Sentman C, Shutter J, Hockenbery D, Kanagawa O, Korsmeyer S. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991; 67:879-88.
19. Cohen J, Duke R, Fadok V, Sellins K. Apoptosis and programmed cell death in immunity. Immunol Rev 1992; 10:267-93.
20. Garchon H, Luan J, Eloy L, Bédossa P, Bach J. Genetic analysis of immune dysfunction in NOD mice: mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction. Eur J Immunol 1994; 24:380-4.
21. Leijon K, Hammarström B, Holmberg D. NOD mice display enhanced immune responses and prolonged survival of lymphoid cells. Int Immunol 1994; 6:339-45.
22. Penha-Goncalves C, Leijon K, Persson L, Holmberg D. Type I diabetes and the control of dexamethasone-induced apoptosis in mice maps to the same region on chromosome 6. Genomics 1995; 28:398-404.
23. Colucci F, Cilio C, Leijon K, Penha-Goncalves C, Bergman M, Holmberg D. Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide. J Autoimmun 1996; 9:271-6.
24. 3 induces apoptosis in stimulated T cells through an IL-2-dependent mechanism. Cytokine 1996; 8:342-5.
25. Elstner E, Linker-Israeli M, Umiel T et al. Combination of a potent 20-epi-Vitamin D3 analogue with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res 1996; 56:3570-6.
26. Welsh J. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol 1994; 72:537-45.
27. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
28. Heid C, Stevens J, Livak K, Williams P. Real time quantitative PCR. Genome Res 1996; 6:986-94.
29. Gibson U, Heid C, Williams P. A novel method for real time quantitative RT-PCR. Genome Res 1996; 6:995-1001.
30. Fox C, Danska J. IL4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J Immunol 1997; 158:2414-24.
31. Faulkner-Jones B, Dempsey-Collier M, Mandel T, Harrison L. Both Th1 and Th2 cytokine mRNAs are expressed in the NOD mouse pancreas in vivo. Autoimmunity 1996 23:99-110.
32. 3, KH1060. Endocrinol 1995; 136:866-72.
33. Clark S, Stumpf W, Sar M. Effects of 1,25 dihydroxyvitamin D3 on insulin secretion. Diabetes 1981; 30:382-6.
34. Billaudel B, Faure A, Sutter B. Effects of 1,25 dihydroxyvitamin D3 on isolated islets from vitamin D3-deprived rats. Am J Physiol 1990; 258:E643-8.
35. Bourlon M, Faure-Dussert A, Billaudel B, Sutter B, Tramu G, Thomasset M. Relationship between calbindin-D28K levels in the A and B cells of the rat endocrine pancreas and the secretion of insulin and glucagon: influence of vitamin D3 deficiency and 1,25-dihydroxyvitamin D3. J Endocrinol 1996; 148:223-32.
36. Sandler S, Buschard K, Bendtzen K. Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1β-induced inhibition of rat pancreatic islet β-cell function in vitro. Immunol Letters 1994; 41:73-77.